Hugo Thomas Torquil Mackenzie-Smith
Director/Board Member at Ellenborough Park Hotel
Profile
Hugo Thomas Torquil Mackenzie-Smith has held director positions at Immodulon Therapeutics Ltd.
since 2009 and at Ellenborough Park Hotel since 2012.
Hugo Thomas Torquil Mackenzie-Smith active positions
Companies | Position | Start |
---|---|---|
Ellenborough Park Hotel
Ellenborough Park Hotel Hotels/Resorts/Cruise linesConsumer Services Part of Shetland Business Ltd., Ellenborough Park Hotel is a luxury 5-star hotel located in Cheltenham, UK. In addition to its luxurious accommodations, Ellenborough Park Hotel also offers exciting activities such as husky driving and archery to showcase the best of the Cotswolds. Founded in 2008, the hotel offers a uniquely charming corporate meeting event venue, spa, and a range of dining options including alfresco dining. | Director/Board Member | 17/01/2012 |
Immodulon Therapeutics Ltd.
Immodulon Therapeutics Ltd. BiotechnologyHealth Technology Part of Lifexx SA, Immodulon Therapeutics Ltd. is a late-stage clinical biotechnology company based in Uxbridge, UK. Immodulon is developing a highly differentiated cancer immunotherapy approach that primes the patient’s own innate immune system with the aim to significantly enhance the efficacy of a broad range of anti-cancer therapies, including chemotherapy and checkpoint inhibitors. The British company is developing imm-101, a heat-killed mycobacterium obuense, as a broad-spectrum immunomodulatory agent with the potential to treat a range of difficult-to-treat tumors including those considered to be immunologically “ cold, ” such as pancreatic cancer. Immodulon's imm-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. The company is focused on developing safe and effective immunotherapy treatments. The company was founded in 2007 by Charles Akle, John L. Stanford. Gertjan Bartlema has been the CEO of the company since 2022. | Director/Board Member | 01/01/2009 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Ellenborough Park Hotel
Ellenborough Park Hotel Hotels/Resorts/Cruise linesConsumer Services Part of Shetland Business Ltd., Ellenborough Park Hotel is a luxury 5-star hotel located in Cheltenham, UK. In addition to its luxurious accommodations, Ellenborough Park Hotel also offers exciting activities such as husky driving and archery to showcase the best of the Cotswolds. Founded in 2008, the hotel offers a uniquely charming corporate meeting event venue, spa, and a range of dining options including alfresco dining. | Consumer Services |
Immodulon Therapeutics Ltd.
Immodulon Therapeutics Ltd. BiotechnologyHealth Technology Part of Lifexx SA, Immodulon Therapeutics Ltd. is a late-stage clinical biotechnology company based in Uxbridge, UK. Immodulon is developing a highly differentiated cancer immunotherapy approach that primes the patient’s own innate immune system with the aim to significantly enhance the efficacy of a broad range of anti-cancer therapies, including chemotherapy and checkpoint inhibitors. The British company is developing imm-101, a heat-killed mycobacterium obuense, as a broad-spectrum immunomodulatory agent with the potential to treat a range of difficult-to-treat tumors including those considered to be immunologically “ cold, ” such as pancreatic cancer. Immodulon's imm-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. The company is focused on developing safe and effective immunotherapy treatments. The company was founded in 2007 by Charles Akle, John L. Stanford. Gertjan Bartlema has been the CEO of the company since 2022. | Health Technology |
- Stock Market
- Insiders
- Hugo Thomas Torquil Mackenzie-Smith